Henry W. Pauls

1.9k citations

44 papers · 943 indexed · h-index 17

Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 14
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
Organic Chemistry top 5%
- Carbohydrate Chemistry and Synthesis 8
- Synthesis and Biological Evaluation 4
Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 6
Computational Theory and Mathematics top 5%
Molecular Biology
- Chemical Synthesis and Analysis 7
- Glycosylation and Glycoproteins Research 3
Cardiology and Cardiovascular Medicine
- Atrial Fibrillation Management and Outcomes 6

Co-authors: William R. Ewing Bert Fraser‐Reid Alfred P. Spada Yong Mi Choi-Sledeski Michael R. Becker J.P. Guilloteau S. Maignan Vincent Mikol
Cited by: Hematology Molecular Medicine Organic Chemistry
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Medicinal Chemistry (3 papers)Journal of the American Chemical Society (2 papers)
Partner nations: United States Canada France

In The Last Decade

Henry W. Pauls

43 papers receiving 880 citations

Peers

Countries citing papers authored by Henry W. Pauls

Since Specialization

Citations

This map shows the geographic impact of Henry W. Pauls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry W. Pauls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry W. Pauls more than expected).

Fields of papers citing papers by Henry W. Pauls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry W. Pauls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry W. Pauls. The network helps show where Henry W. Pauls may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Henry W. Pauls, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Henry W. Pauls Line = papers co-authored together Henry W. Pauls links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics Journal of Chemotherapy ·Nachum Kaplan,Donald E. Awrey,Steven S. Vickner,Judd Berman,Jeremy A. Yethon,Henry W. Pauls,Barry Hafkin	2013	29
2	Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor Antimicrobial Agents and Chemotherapy ·Nachum Kaplan,Monique Albert,Donald E. Awrey,Steven S. Vickner,Judd Berman,Teresa E. Clarke,Mei‐Yi Lee,Barry Hafkin,Marian White Bannerman,V. Romanov,Molly B. Schmid,晃生加藤,Jeremy A. Yethon,Henry W. Pauls	2012	92
3	Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent Bioorganic & Medicinal Chemistry Letters ·Guyan Liang,Suzanne C. Aldous,Ashirdbad Sarangi,Julian Levell,MAGON D.P.S.,Jennifer Cairns,Xin Chen,S. Maignan,Magali Mathieu,А.П. Савельев,B Saritha,Sam Rebello,Khalil Sammad,Isabelle Morize,Henry W. Pauls	2011	16
4	Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI) Bioorganic & Medicinal Chemistry Letters ·Peter B. Sampson,Christine J. Picard,美彦西村,Eulina Barbosa Nery,Marwa Houalla,Andrew Leeson,V. Romanov,Donald E. Awrey,关道雄,Steven S. Vickner,Nachum Kaplan,Judd Berman,Henry W. Pauls	2009	17
5	Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase Bioorganic & Medicinal Chemistry Letters ·Corey R. Hopkins,معصومه زری بافان,Steven S. Kaye,Lourenço Jorge Magner,MAGON D.P.S.,Henry W. Pauls,Guyan Liang,B Saritha,V. G. Vlasov,Jennifer Cairns,Francisca Ugarte P,Antonio DeGrasse,K. Maruszewskia,Sam Rebello,John V. Spears,A. Dupuy,Magali Mathieu,Julian Levell	2005	29
6	Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation Bioorganic & Medicinal Chemistry Letters ·Corey R. Hopkins,Kent Neuenschwander,達矢竹島,Sharon Jackson,Thaddeus R. Nieduzak,Henry W. Pauls,Guyan Liang,B Saritha,V. G. Vlasov,Jennifer Cairns,S. Maignan,Magali Mathieu	2004	20
7	Optimization of the β-Aminoester class of factor Xa inhibitors. part 1: P4 and side-Chain modifications for improved In vitro potency Bioorganic & Medicinal Chemistry Letters ·معصومه زری بافان,Scott I. Klein,Kevin R. Guertin,Shipu Zheng,Allison L. Zulli,Henry W. Pauls,Alfred P. Spada,Daniel L. Cheney,Karen Brown,Dennis Colussi,Valeria Chu,Robert J. Leadley,Christopher T. Dunwiddie	2002	14
8	Optimization of the β-Aminoester class of factor Xa inhibitors. part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity Bioorganic & Medicinal Chemistry Letters ·Kevin R. Guertin,Shipu Zheng,Scott I. Klein,Allison L. Zulli,معصومه زری بافان,Yong Gong,Alfred P. Spada,Daniel L. Cheney,John V. Spears,J.P. Guilloteau,Karen Brown,Dennis Colussi,Valeria Chu,Christopher L. Heran,İlke Kavuşturan,Ross Bentley,Christopher T. Dunwiddie,Robert J. Leadley,Henry W. Pauls	2002	45
9	The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa Current Topics in Medicinal Chemistry ·Henry W. Pauls,William R. Ewing	2001	27
10	Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa Bioorganic & Medicinal Chemistry Letters ·Yong Gong,Henry W. Pauls,Alfred P. Spada,معصومه زری بافان,Guyan Liang,Valeria Chu,Dennis Colussi,Karen Brown,Jingbo Gao	2000	9
11	Solid-phase parallel synthesis of azarene pyrrolidinones as factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Yong Gong,Michael R. Becker,Yong Mi Choi-Sledeski,谷川俊貴,Joseph M. Salvino,Valeria Chu,Karen Brown,Henry W. Pauls	2000	13
12	In Vitro Characterization of a Novel Factor Xa Inhibitor, RPR 130737 Thrombosis Research ·Valeria Chu,Karen Brown,Dennis Colussi,G. Linscott,Dan Green,Henry W. Pauls,Alfred P. Spada,Mark H. Perrone,Robert J. Leadley,Christopher T. Dunwiddie	2000	16
13	Synthesis, SAR and in vivo activity of novel thienopyridine sulfonamide pyrrolidinones as factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael R. Becker,William R. Ewing,谷川俊貴,Henry W. Pauls,Cuong Q. Ly,محمد حساين,Helen J. Mason,Yong Mi Choi-Sledeski,Alfred P. Spada,Valeria Chu,Karen Brown,Dennis Colussi,Robert J. Leadley,Ross Bentley,Щеблыкин Сергей Иванович,Charles Kasiewski,İlke Kavuşturan	1999	19
14	Pharmacodynamic Activity and Antithrombotic Efficacy of RPR120844, a Novel Inhibitor of Coagulation Factor Xa Journal of Cardiovascular Pharmacology ·Robert J. Leadley,İlke Kavuşturan,Ross Bentley,Jeffrey S. Bostwick,Charles Kasiewski,Christopher L. Heran,Valeria Chu,Karen Brown,Amy De Los Santos,William R. Ewing,Henry W. Pauls,Alfred P. Spada,Mark H. Perrone,Christopher T. Dunwiddie	1999	15
15	Aminoisoquinolines: Design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA Bioorganic & Medicinal Chemistry Letters ·Yong Mi Choi-Sledeski,Michael R. Becker,M. Murat Naki,袁菡苓,William R. Ewing,Helen J. Mason,Cuong Q. Ly,Verónica Melendres Acevedo,Guyan Liang,Daniel L. Cheney,Diana Spiekhout,Valeria Chu,Karen Brown,Dennis Colussi,Ross Bentley,Robert J. Leadley,Christopher T. Dunwiddie,Henry W. Pauls	1999	20
16	Characterization of the bisphosphonate recognition site on hydroxyapatite using radioligand binding techniques with [14C]citric acid Calcified Tissue International ·Michael F. Jarvis,Carol J. Burns,Henry W. Pauls,Prita Ayu Kusumawardani Kusumawardani,Brian Vigil,Daniel L. Cheney,Raymond D. Youssefyeh	1993	10
17	Irreversible Inhibition of Transglutaminases by Sulfonium Methylketones: Optimization of Specificity and Potency with w-Aminoacyl Spacers Journal of enzyme inhibition ·Diana H. Pliura,H. Danneel,Henry W. Pauls,贺志理,Allen Krantz	1992	13
18	New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy Journal of the American Chemical Society ·Roger A. Smith,Leslie J. Copp,Peter J. Coles,Henry W. Pauls,Valerie J. Robinson,Robin W. Spencer,Stephen B. Heard,Allen Krantz	1988	53
19	Stereocontrolled routes to cis-hydroxyamino sugars. Part VI. A synthesis of garosamine Canadian Journal of Chemistry ·Henry W. Pauls,Bert Fraser‐Reid	1984	10
20	An efficient synthesis of ristosamine utilizing the allylic hydroxyl of a hex-2-enopyranoside The Journal of Organic Chemistry ·Henry W. Pauls,Bert Fraser‐Reid	1983	24

About Henry W. Pauls

Henry W. Pauls is a scholar working on Hematology, Molecular Medicine and Organic Chemistry, having authored 44 papers that have together received 943 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (14 papers), Carbohydrate Chemistry and Synthesis (8 papers), Chemical Synthesis and Analysis (7 papers), Atrial Fibrillation Management and Outcomes (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Synthesis and Biological Evaluation (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Hematology (215 citations), Molecular Medicine (80 citations) and Organic Chemistry (368 citations). Henry W. Pauls has collaborated with scholars based in United States, Canada and France. Frequent co-authors include William R. Ewing, Bert Fraser‐Reid, Alfred P. Spada, Yong Mi Choi-Sledeski, Michael R. Becker, J.P. Guilloteau, S. Maignan, Vincent Mikol, Scott I. Klein and Valeria Chu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of the American Chemical Society, Current Topics in Medicinal Chemistry and Canadian Journal of Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact